AbbVie Newsroom

Deutsche Bank Adjusts AbbVie Price Target to $180 From $175, Maintains Hold Rating

MT NewswiresNov 5 07:45 ET

AbbVie Analyst Ratings

BenzingaNov 4 11:29 ET

Argus Research Upgrades AbbVie(ABBV.US) to Buy Rating

Moomoo NewsNov 4 08:31 ET

Goldman Sachs Raises Price Target on AbbVie to $210 From $208

MT NewswiresNov 1 11:59 ET

Barclays Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $212

Moomoo NewsNov 1 06:32 ET

AbbVie Price Target Raised to $200.00/Share From $195.00 by UBS

Dow JonesOct 31 15:46 ET

AbbVie Is Maintained at Neutral by UBS

Dow JonesOct 31 15:46 ET

Cantor Fitzgerald Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $240

Moomoo NewsOct 31 09:31 ET

Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $231

Moomoo NewsOct 31 09:31 ET

A Quick Look at Today's Ratings for AbbVie(ABBV.US), With a Forecast Between $205 to $240

Moomoo NewsOct 31 09:19 ET

AbbVie Analyst Ratings

BenzingaOct 31 08:53 ET

Morgan Stanley Raises Price Target on AbbVie to $231 From $218, Keeps Overweight Rating

MT NewswiresOct 31 06:36 ET

Evercore ISI Adjusts Price Target on AbbVie to $204 From $192

MT NewswiresOct 30 13:57 ET

Leerink Partners Maintains AbbVie(ABBV.US) With Hold Rating

Moomoo NewsOct 29 08:32 ET

AbbVie Is Maintained at Buy by Citigroup

Dow JonesOct 25 14:33 ET

AbbVie Analyst Ratings

BenzingaOct 25 14:23 ET

Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $209

Moomoo NewsOct 23 08:31 ET

Leerink Partners Maintains AbbVie(ABBV.US) With Hold Rating, Announces Target Price $206

Moomoo NewsOct 23 03:33 ET

AbbVie: Balanced Outlook Amid EPS Adjustments and Pipeline Uncertainties Warrants Hold Rating

TipRanksOct 23 02:47 ET

Goldman Sachs Adjusts Price Target on AbbVie to $208 From $200

MT NewswiresOct 21 08:19 ET